BioNTech SE (BNTX) Interest Coverage Ratio Growth (1y) (2019 - 2025)
BioNTech SE (BNTX) Interest Coverage Ratio Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 73.00% |
| 10 | BioNTech SE | 21.56 Bn | 21.56 Bn | 668.28 Mn | 751.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 751.68% |
| Sep 30, 2025 | 241.80% |
| Jun 30, 2025 | -45.91% |
| Mar 31, 2025 | -85.40% |
| Dec 31, 2024 | 43.52% |
| Sep 30, 2024 | 96.41% |
| Jun 30, 2024 | -69.45% |
| Mar 31, 2024 | 578.23% |
| Dec 31, 2023 | -0.89% |
| Sep 30, 2023 | 95.08% |
| Jun 30, 2023 | 152.88% |
| Mar 31, 2023 | 97.23% |
| Dec 31, 2022 | 97.31% |
| Sep 30, 2022 | -1,199.35% |
| Jun 30, 2022 | -3,533.16% |
| Mar 31, 2022 | -2,290.34% |
| Dec 31, 2021 | -14,108.06% |
| Sep 30, 2021 | -746.54% |
| Mar 31, 2021 | 131.35% |
| Dec 31, 2020 | 106.24% |